Resultats de la cerca - Paolo de Fabritiis

Refinar resultats
  1. 1
    TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?

    TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge? per Matteo Molica, Carla Mazzone, Pasquale Niscola, Paolo de Fabritiis

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    TYROSINE KINASE INHIBITORS AND PREGNANCY

    TYROSINE KINASE INHIBITORS AND PREGNANCY per Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo de Fabritiis, Alessio Perrotti

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Pain Syndromes in Sickle Cell Disease: An Update

    Pain Syndromes in Sickle Cell Disease: An Update per Pasquale Niscola, Francesco Sorrentino, Laura Scaramucci, Paolo de Fabritiis, Paolo Cianciulli

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    SARS‐CoV‐2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies

    SARS‐CoV‐2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies per Matteo Molica, Carla Mazzone, Iole Cordone, Alessia Pasquale, Pasquale Niscola, Paolo de Fabritiis

    Publicat 2020
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  5. 5
    Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms

    Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms per Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, Daniela Piccioni, Carla Mazzone, Paolo de Fabritiis

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Menin Inhibitors: New Targeted Therapies for Specific Genetic Subtypes of Difficult-to-Treat Acute Leukemias

    Menin Inhibitors: New Targeted Therapies for Specific Genetic Subtypes of Difficult-to-Treat Acute Leukemias per Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, Daniela Piccioni, Carla Mazzone, Paolo de Fabritiis

    Publicat 2025
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection

    SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection per Elisabetta Abruzzese, Luigia Luciano, Francesco D’Agostino, Malgorzata Monika Trawinska, Fabrizio Pane, Paolo de Fabritiis

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  8. 8
    CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin

    CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin per Matteo Molica, Salvatore Perrone, Carla Mazzone, Pasquale Niscola, Laura Cesini, Elisabetta Abruzzese, Paolo de Fabritiis

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Mucositis in patients with hematologic malignancies: an overview

    Mucositis in patients with hematologic malignancies: an overview per Pasquale Niscola, Claudio Romani, Luca Cupelli, L. Scaramucci, Andrea Tendas, T Dentamaro, Sergio Amadori, Paolo de Fabritiis

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement

    Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement per Paolo de Fabritiis, Marco Bregni, Jeffrey M. Lipton, Joel S. Greenberger, L M Nadler, Lisa Rothstein, M Körbling, Jerome Ritz, RC Jr Bast

    Publicat 1985
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B‐cell chronic lymphocytic leukemia

    Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B‐cell chronic lymphocytic leukemia per Giovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Giovanni Capelli, Fabrizio Luciano, Alessio Perrotti, Massimo Degan, Adriano Venditti, Paolo de Fabritiis, Valter Gattei, Sergio Amadori

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

    Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patie... per Elisabetta Abruzzese, Monica Bocchia, Malgorzata Monika Trawinska, Donatella Raspadori, Francesco Bondanini, Anna Sicuranza, Paola Pacelli, Federica Re, Alessia Cavalleri, Mirko Farina, Michele Malagola, Domenico Russo, Paolo de Fabritiis, Simona Bernardi

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

    Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow per Luca Maurillo, Francesco Buccisano, Alessandra Spagnoli, Giovanni Del Poeta, P. Panetta, Bruno Neri, Maria Ilaria Del Principe, Carla Mazzone, Maria Irno Consalvo, Anna Tamburini, Letizia Ottaviani, Daniela Fraboni, Chiara Sarlo, Paolo de Fabritiis, Sergio Amadori, Adriano Venditti

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers

    Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers per Wilma Barcellini, Anna Zaninoni, Bruno Fattizzo, Juri Alessandro Giannotta, Monia Lunghi, Antonella Ferrari, Anna Paola Leporace, Nilla Maschio, Laura Scaramucci, Silvia Cantoni, Federico Chiurazzi, Dario Consonni, Giuseppe Rossi, Paolo de Fabritiis, Gianluca Gaïdano, Alberto Zanella, Agostino Cortelezzi

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  15. 15
    Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

    Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia per Maria Ilaria Del Principe, Michele Dal Bo, Tamara Bittolo, Francesco Buccisano, Francesca Maria Rossi, Antonella Zucchetto, Davide Rossi, Riccardo Bomben, Luca Maurillo, Mariagiovanna Cefalo, Giovanna De Santis, Adriano Venditti, Gianluca Gaïdano, Sergio Amadori, Paolo de Fabritiis, Valter Gattei, Giovanni Del Poeta

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study

    A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study per Sabina Chiaretti, Alessandro Vitale, Marco Vignetti, Alfonso Piciocchi, Paola Fazi, L Elia, Brunangelo Falini, Francesca Ronco, Francesca Ferrara, Paolo de Fabritiis, Mario Luppi, Giorgio La Nasa, Andrea Tedeschi, C. Califano, R. Fanin, Sylvain Doré, Franco Mandelli, Giovanna Meloni, R. Foà

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia

    Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia per Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Giovanni Del Poeta, Alessandra Spagnoli, Paola Panetta, Emanuele Ammatuna, Benedetta Neri, Licia Ottaviani, Chiara Sarlo, Daniela Venditti, Micol Quaresima, Raffaella Cerretti, Manuela Rizzo, Paolo de Fabritiis, Francesco Lo‐Coco, William Arcese, Sergio Amadori, Adriano Venditti

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry

    Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry per Ekaterina Chelysheva, Jane F. Apperley, Anna Turkina, Mohamed A. Yassin, Delphine Réa, Franck E. Nicolini, Daniela Barraco, Khamida Kazakbaeva, Sukhrob Saliev, Adi Shacham Abulafia, Salam Alkindi, Jenny Byrne, Harry F. Robertson, Marco Cerrano, R.G. Shmakov, Evgenia Polushkina, Paolo de Fabritiis, Malgorzata Monika Trawinska, Elisabetta Abruzzese

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

    Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Pha... per Sergio Amadori, Stefan Suciu, Dominik Selleslag, Franco Aversa, Gianluca Gaïdano, Maurizio Musso, Luciana Annino, Adriano Venditti, Maria Teresa Voso, Carla Mazzone, Domenico Magro, Paolo de Fabritiis, Petra Muus, Giuliana Alimena, Marco Mancini, Anne Hagemeijer, Francesca Paoloni, Marco Vignetti, Paola Fazi, Liv Meert, Safaa Ramadan, Roel Willemze, Théo de Witte, Frédéric Baron

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

    Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients per Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni, Tommaso Radice, Ilaria Nichele, Eros Di Bona, Monia Lunghi, Cristina Tassinari, Fiorella Alfinito, Antonella Ferrari, Anna Paola Leporace, Pasquale Niscola, Monica Carpenedo, Carla Boschetti, Nicoletta Revelli, Maria Antonietta Villa, Dario Consonni, Laura Scaramucci, Paolo de Fabritiis, Giuseppe Tagariello, Gianluca Gaïdano, Francesco Rodeghiero, Agostino Cortelezzi, Alberto Zanella

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: